Shares of PMGC Holdings Inc. (NASDAQ:ELAB) are trading higher on Monday after the company announced one of its subsidiaries, NorthStrive Biosciences, transferred a key project to a U.S.-based third-party fermentation facility.

PMGC Solidifies Biosciences Scaling Strategy

NorthStrive Biosciences, a wholly owned subsidiary of PMGC Holdings, announced the successful transfer of the EL-32 Working Cell Bank to a U.S.-based third-party fermentation facility. EL-32 is an experimental probiotic therapy designed to help maintain muscle and improve metabolism. The goal is to help people who lose muscle while using GLP-1 weight loss drugs.

Modulant Biosciences has retained the third-party precision fermentation facility to lead upstream and downstream process development.

The collaboration reflects a dual-track development strategy: NorthStrive Biosciences retains all rights to human therapeutic applications of EL-32, while Modulant Biosciences holds an exclusive license to develop and commercialize EL-32-derived products for non-human animal health applications. 

ELAB Shares Trade Above Key Averages

ELAB is trading 11.3% above its 20-day simple moving average (SMA), which suggests short-term stabilization is trying to take hold. At the same time, it's trading 86.9% below its 100-day SMA, which indicates the intermediate trend remains heavily pressured.

Moving average convergence divergence (MACD), a trend/momentum measure, is showing a bullish setup with the MACD above the signal line, which suggests downside momentum is easing versus recent weeks. That said, the 20-day SMA remains below the 50-day SMA and the 50-day SMA is below the 200-day SMA, a combination that keeps the longer-term trend biased bearish until price can reclaim more overhead levels.

  • Key Resistance: $7.00 — near the 50-day SMA area where rebounds can run into supply.
  • Key Support: $4.00 — the nearby floor traders often watch for failed bounces.

ELAB Shares Rise Monday

ELAB Stock Price Activity: PMGC Holdings shares were up 2.71% at $4.92 at the time of publication on Monday, according to Benzinga Pro data.

Image: Shutterstock